Market Place
Sourcing Support
Sanofi’s Venglustat Earns BTD in US for Type 3 Gaucher Disease
18 Mar 2026 //
GLOBENEWSWIRE
Sanofi Rare Disease Drug Shows Success And Failure In Phase 3
02 Feb 2026 //
PRESS RELEASE
Sanofi hit by filing delays for key drugs
29 Oct 2021 //
FIERCEBIOTECH
Sanofi halts venglustat clinical programme in ADPKD
02 Jun 2021 //
PHARMATIMES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.